[wpbb post:title]
Past Forums
Artificial Intelligence
BostonApril 23-25, 2018
Cancer
BostonApril 25-27, 2016
Cardiovascular
BostonMay 1-3, 2017
Neuroscience
BostonApril 27-29, 2015
Neuroscience
LondonMarch 27, 2017
Past Forum Keynoters
CEOs
- Jani Ahonala
CEO, Noona Healthcare - Stéphane Bancel
CEO, Moderna Therapeutics - George Barrett
CEO, Cardinal Health - Fabien Beckers, PhD
CEO, Arterys - Mark Bertolini
CEO, Aetna - Katrine Bosley
CEO, Editas Medicine - Robert Bradway
CEO, Amgen - Nancy Brown
CEO, American Heart Association - Dan Burton
CEO, Health Catalyst - Giovanni Caforio, MD
CEO, Bristol-Myers Squibb - Robert Califf, MD
Commissioner (former), Food and Drug Administration - Peter Chiarelli
CEO, One Mind for Research - Tony Coles, MD
CEO, Yumanity Therapeutics - Patrick Conway, MD
CEO, BCBS of North Carolina - Marc de Garidel
CEO, Ipsen - Louis DeGennaro, PhD
President and CEO, The Leukemia & Lymphoma Society - Susan Dentzer
CEO, Network for Excellence in Health Innovation - Keith Dionne, PhD
CEO, Constellation Pharmaceuticals - Deborah Dunsire, MD
CEO, XTuit Pharmaceuticals - Helmy Eltoukhy, PhD
CEO, Guardant Health - Maurice Ferre, MD
CEO, Insightec - Frank Fischer
CEO, NeuroPace - John Flannery
CEO, GE Healthcare - Paul Fonteyne
CEO, Boehringer-Ingelheim USA - Peter Ford
Founder and CEO, Control Bionics - Richard Gonzalez
CEO, AbbVie - Colin Hill
CEO, GNS Healthcare - Andew Hopkins
CEO, Exscientia - Jensen Huang
CEO, NVIDIA - Thomas Hughes, PhD
CEO, Zafgen - Jackie Hunter, PhD
CEO, Benevolent AI - Jeff Immelt
CEO, General Electric - Omar Ishrak, PhD
CEO, Medtronic - Joseph Jachinowski
CEO, Mevion Medical Systems - Joseph Jimenez
CEO, Novartis - Karim Karti
CEO, GE Healthcare Imaging - Krishna Kumar
CEO, Emerging Businesses, Philips - John Lechleiter, PhD
Chairman, Eli Lilly and Company - David Lee
CEO, Lumicell - Jeffrey Leiden, MD, PhD
CEO, Vertex Pharmaceuticals - Noga Leviner
CEO, Picnic Health - Michael Mahoney
CEO, Boston Scientific - John Maraganore, PhD
CEO, Alnylam - Corey McCann, MD, PhD
Founder and CEO, Pear Therapeutics - Martin McGlynn
CEO, StemCells - Clive Meanwell, MD, PhD
CEO, The Medicines Company - David Meeker, MD
CEO, Genzyme - Michael Minogue
CEO, Abiomed - Bernd Montag, PhD
CEO, Siemens Healthineers - Briggs Morrison, MD
CEO, Syndax Pharmaceuticals - Robert Mulroy
CEO, Merrimack Pharmaceuticals - Michael Mussallem
CEO, Edwards Lifesciences - Vasant Narasimhan, MD
CEO, Novartis - Diana Nole
CEO, Wolters Kluwer Health - Gabriel Otte
CEO, Freenome - Michael Pellini, PhD
CEO, Foundation Medicine - Gary Reedy
CEO, American Cancer Society - Jonathan Rennert
CEO, ZOLL Medical - Paul Ricci
Former Chairman and CEO, Nuance Communications - Timothy Ring
CEO, Bard - Johnathan Rothberg, PhD
Founder and CEO, Butterfly Network - Judy Salerno, MD
CEO, Susan G. Komen for the Cure - Satish Sanan
CEO, Inspirata - George Scangos, PhD
CEO, Biogen - Dale Schenk, PhD
CEO, Prothena - Todd Sherer, PhD
CEO, The Michael J. Fox Foundation for Parkinson’s Research - Sue Siegel
CEO, GE Ventures & healthymagination - Nancy Simonian, MD
CEO, Syros Pharmaceuticals - Punit Soni
CEO, Robin AI - David Torchiana, MD
CEO, Partners HealthCare - Steven Tregay, PhD
CEO, Forma Therapeutics - Chuck Wilson, PhD
CEO, Unum Therapeutics - Dow Wilson
CEO, Varian Medical Systems - Frans van Houten
CEO, Philips
Executives, Investors, Philanthropic and Government Leads
- Amy Abernethy, MD, PhD
CMO, CSO & SVP Oncology, Flitiron Health - Philip Adamson, MD
VP and Medical Director, Abbott - Julia Beaver, MD
Acting Clinical Team Leader, Division of Oncology Products 1, CDER, FDA - Roy Beveridge, MD
SVP and CMO, Humana - Morris Birnbaum, MD, PhD
SVP and CSO, CVMET, Pfizer - Daniel Bloomfield, MD
SVP, Global Clinical Research, Therapeutic Area Head, Cardiometabolic & Womens Health, MRL Lead, China R&D, Merck - Jay Bradner, MD
President, Novartis Institutes for Biomedical Research - Troy Brennan, MD
EVP and CMO, CVS Health - Terri Bresenham
Chief Innovation Officer, GE Healthcare - Carsten Brunn, PhD
Head of Pharmaceuticals, Americas Region, Bayer - Iain Buchan, MD
Director of Healthcare Research, Microsoft Research - Hon, Sylvia Mathews Burwell
Secretary, U.S. Health and Human Services - Doug Cole, MD
General Partner, Flagship Ventures - Meryl Comer
President, Geoffrey Beene Foundation Alzheimer’s Initiative - Robert Copeland, PhD
President, Research and CSO, Epizyme - Newt Crenshaw
VP, North America Oncology, Eli Lilly and Company - Francis Cuss, MD
EVO and CSO, R&D, Bristol-Myers Squibb - Leonard D’Avolio, PhD
CEO, Cyft, Inc. - Michael Dale
Divisional VP and General Manager, Structural Heart, Abbott - Thomas Daniel, MD
Chairman, Celgene Research - Jens Eckstein, PhD
President, SR One - Steve Fawell, PhD
VP, Head Oncology iScience, AstraZeneca - Robert Ford
EVP, Medical Devices, Abbott - Jean-François Formela, MD
Partner, Atlas Venture - Colleen Fowler
VP, GM, AF Solutions, Medtronic - Pete Frates
Champion, ALS Ice Bucket Challenge - Jamie Freedman, MD, PhD
SVP, Global Clinical Development, Medimmune - Mark Frohlich, MD
EVP, Portfolio Strategy, Juno Therapeutics - Gary Gibbons, MD
Director, National Heart,&bnsp;Lung, and Blood Institute (NHLBI) - Kathy Giusti
Founder, MMRF and Multiple Myeloma Research Consortium - Corey Goodman, PhD
Managing Partner, venBio - Jeffrey Gulcher, MD, PhD
President and CSO, NextCODE Health - Adele Gulfo
EVP & Head, Global Commercial Development, Mylan; Director, Bemis, Inc. - Atul Gawande, MD
Ariadne Labs; Samuel O. Thier Professor of Surgery, HMS; Surgeon, BWH - Sean Harper, MD
EVP, R&D, Amgen - Seth Hain
Director, Analytics & Machine Learning, Epic - William Hait, MD, PhD
Global Head, Janssen Research & Development, J&J - Ludovic Helfgott
Global VP, Cardiovascular, Renal and Metabolism, AstraZeneca - Paul Hudson
President, AstraZeneca US and EVP, North America - Michael Hutton, PhD
CSO, Neurodegenerative Diseases, Eli Lilly and Company - Rajiv Kaul
Select Biotechnology Portfolio and Advisor Biotechnology Fund, Fidelity Investments - Hiroyuki Kawabata
Director, Health & Welfare Department, JETRO New York - Allison Kean, MD
CV Therapeutic Area Lead, Global Business Development, Pfizer - John Kelly, PhD
SVP, Cognitive Solutions and Research, IBM - Aarif Khakoo, MD
VP Research, Cardiometabolic Disorders Therapeutic Area Head, Site Head Amgen San Francisco, Amgen - Maria Koehler, MD, PhD
VP, Strategy, Innovation and Collaborations, Pfizer Oncology Business Unit - Lothar Krinke, PhD
VP and GM, Brain Modulation, Medtronic - Paul LaViolette
Managing Partner and COO, SV Life Sciences Advisers - Peter Lebowitz, MD, PhD
Global Therapeutic Area Head, Oncology, Janssen R&D - Jonathan Leff
Partner, Deerfield Management - Gillian Leng, MD
Deputy Chief Executive, Director of Health and Social Care, National Institute for Health and Care Excellence - John Lepore, MD
SVP, R&D Pipeline, GlaxoSmithKline - Dean Li, MD, PhD
VP, Head Translational Medicine, Merck - Geoffrey Ling, MD, PhD
Director, Biological Technologies Office, DARPA - Thomas Lynch, MD
EVP and CSO, R&D, Bristol-Myers Squibb - Lisa Maki
Co-Founder, Director, PokitDok - Misti Malone, PhD
Chief, Peripheral Interventional Devices Branch, Food and Drug Administration - Shaden Marzouk, MD
CMO, Cardinal Health - Henry McCance
Chairman Emeritus, Greylock Partners, CO-Founder, Cure Alzheimer’s Fund - Jessica Mega, MD
CMO, Verily - Professor Ian Meredith, PhD
EVP, Global CMO, Boston Scientific - Jeff Mirviss
SVP and President, Peripheral Interventions, Boston Scientific - Greg Moore, MD, PhD
VP, Healthcare, Google Cloud - Ryuichi Morishita, MD, PhD
Founder, AnGes - Alan Moses, MD
SVP, Global CMO, Novo Nordisk - Mark Murcko, PhD
CSO, Relay Therapeutics - Amir Nashat, PhD
Managing Partner, Polaris Partners - Peter Orszag, PhD
Vice Chairman, Investment Banking and Managing Director, Lazard Freres - Vijay Pande
Partner, Andreessen Horowitz - Georgia Papathomas, PhD
SVP, Global Head of Data Sciences, Johnson & Johnson - Ora Pescovitz, MD
SVP and US Medical Leader, Eli Lilly and Company - Jonathan Plehn, MD
VP Cardiovascular Medicine, Covance - Miri Polachek
Executive Director, Israel Brain Technologies - Amy Pollack, MD
CMO & VP Global Medical Affairs for the Early Technologies Business Group/Minimally Invasive Technology Innovations (MITG), Medtronic - Sy Pretorius, MD
SVP & CSO, PAREXEL International - David Reese, MD
SVP, Translational Sciences, Amgen - Alessandro Riva, MD
Global Head, Oncology Development and Medical Affairs, Novartis Oncology - James Robinson
President, Americas Operations, Astellas - Ann Romney
Global Ambassador, Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital - Bruce Rosengard, MD
Chief Medical Science and Technology Officer, Johnson & Johnson Medical Devices Companies - Michael Rousseau
President, Cardiovascular and Neuromodulation, Abbott - Sean Salmon
SVP and President, Coronary & Structural Heart, Medtronic - Alfred Sandrock, MD, PhD
Group SVP, CMO, Biogen - Lewis Sandy, MD
EVP, Clinical Advancement, UnitedHealth Group - Joseph Scheeren, PharmD
Senior Advisor, R&D, Bayer - Darryle Schoepp, PhD
VP and Therapeutic Area Head, Neuroscience Early Development and Discovery Sciences, Merck Research Laboratories - William Sellers, MD
VP and Global Head of Oncology, Novartis Institutes for BioMedical Research - Sue Siegel
CIO and CEO, Business Innovations, GE - Andy Slavitt
Acting Administrator, CMS - Craig Sponseller, MD
CMO, Kowa Pharmaceuticals America - Norman Stockbridge, MD, PhD
Director, Division of Cardiovascular and Renal Products, Food and Drug Administration - Bruno Strigini
President, Novartis Oncology - Tamara Syrek Jensen
Director, Coverage and Analysis Group, CMS - Eiji Tanaka, PhD
President, Head of Global Business Development, Mitsubishi Tanabe Pharma Holdings America, Inc. - Robert Tepper, MD
Partner, Third Rock Ventures, Adjunct Professor, HMS - Claire Thom, PharmD
SVP, Global Oncology Development, Astellas - James Topper, MD, PhD
Managing General Partner, Frazier Healthcare Partners - Susan Tousi
SVP, Product Development, Illumina, Inc. - Timothy Tuttle, PhD
CTO, Cognitive Collaboration Group, Cisco - Paul Underwood, MD
Medical Director, Boston Scientific - Mike Vasconcelles, MD
CMO, Unum Therapeutics - Ajay Verma, MD, PhD
VP, Experimental Medicine, Biogen - Christopher Viehbacher
Managing Partner, Gurnet Point Capital - Seema Verma
Administrator, Centers for Medicare and Medicaid Services - Jeff Walker
Vice-Chair, United Nations Envoy’s Office for Health Finance and Malaria - Scott Wasserman, MD
VP, Global Development, Amgen
Popular Panels
2018 WMIF
Fireside Chat: Vasant Narasimhan, MD, CEO, Novartis
- Moderator: Gregg Meyer, MD, Chief Clinical Officer, PHS; Professor of Medicine, MGH and HMS
- Vasant Narasimhan, MD, CEO, Novartis
2015 WMIF
Gene Editing, Gene Therapy, and the Eye as a Gateway
- Moderator: Jennifer Joe, MD, CEO, Medstro, Editor-In-Chief, MedTech Boston
- Katrine Bosley, CEO, Editas Medicine
- Eric Pierce, MD, PhD, Director, Retinal Degenerations Service, Massachusetts Eye and Ear; Solman and Libe Friedman Associate Professor of Ophthalmology, Harvard Medical School
- Philip Gregory, D. Phil, Senior Vice President, Research and CSO, Sangamo BioSciences
- David Meeker, MD, CEO, Genzyme
2016 WMIF
Fireside Chat: Joseph Jimenez, CEO, Novartis
- Moderator: Gregg Meyer, MD, Chief Clinical Officer, Partners HealthCare
- Joseph Jimenez, CEO, Novartis
2016 WMIF
Immunotherapy I: Checkpoint Activation and Cancer Vaccines
- Moderator: Nir Hacohen, PhD, Immunologist, MGH Center for Immunology and Inflammatory Diseases, MGH Research Scholar, Associate Professor, Medicine, Harvard Medical School
- Thomas Daniel, MD, Chairman, Celgene Research
- Glenn Dranoff, MD, Global Head of Exploratory Immuno-Oncology, Novartis Institutes for Biomedical Research
- Robert Mulroy, President and CEO, Merrimack Pharmaceuticals
- David Reese, MD, Senior Vice President, Translational Sciences, Amgen
- Scott Rodig, MD, PhD, Associate Professor, BWH
- Arlene Sharpe, MD, PhD, Leader, Cancer Immunology, BWH, DFCI, George Fabyan Professor of Comparative Pathology, Harvard Medical School
2017 WMIF
1:1 Fireside Chat: Omar Ishrak, PhD, CEO, Medtronic
- Moderator: Paul LaViolette, Managing Partner & COO, SV Life Sciences Advisers
- Omar Ishrak, PhD, CEO, Medtronic
2018 WMIF
1:1 Fireside Chat: Jensen Huang, CEO, NVIDIA
- Introduction: Scott Sperling, Co-President, Thomas H Lee Partners; Chairman of the Board of Directors, PHS
- Moderator: Keith Dreyer, DO, PhD, Chief Data Science Officer, PHS; Vice Chairman, Radiology, MGH; Associate Professor, Radiology, HMS
- Jensen Huang, CEO, NVIDIA